CL2008001128A1 - Asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos, vector y celula huesped; metodo para producir asparraginasa; composicion que comprende variante; uso de la variante de asparraginasa; proceso de elaboracion - Google Patents

Asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos, vector y celula huesped; metodo para producir asparraginasa; composicion que comprende variante; uso de la variante de asparraginasa; proceso de elaboracion

Info

Publication number
CL2008001128A1
CL2008001128A1 CL200801128A CL2008001128A CL2008001128A1 CL 2008001128 A1 CL2008001128 A1 CL 2008001128A1 CL 200801128 A CL200801128 A CL 200801128A CL 2008001128 A CL2008001128 A CL 2008001128A CL 2008001128 A1 CL2008001128 A1 CL 2008001128A1
Authority
CL
Chile
Prior art keywords
asparraginase
variante
codifies
understands
vector
Prior art date
Application number
CL200801128A
Other languages
English (en)
Inventor
Van Dder Jan Metske Stor Laan
Original Assignee
Dsm Ip Asssets B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Asssets B V filed Critical Dsm Ip Asssets B V
Publication of CL2008001128A1 publication Critical patent/CL2008001128A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/06—Enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A23L5/25—Removal of unwanted matter, e.g. deodorisation or detoxification using enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01001—Asparaginase (3.5.1.1)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CL200801128A 2007-04-20 2008-04-18 Asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos, vector y celula huesped; metodo para producir asparraginasa; composicion que comprende variante; uso de la variante de asparraginasa; proceso de elaboracion CL2008001128A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07106660 2007-04-20
EP07106664 2007-04-20
EP07106662 2007-04-20

Publications (1)

Publication Number Publication Date
CL2008001128A1 true CL2008001128A1 (es) 2008-06-13

Family

ID=39650693

Family Applications (2)

Application Number Title Priority Date Filing Date
CL200801129A CL2008001129A1 (es) 2007-04-20 2008-04-18 Variente de asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos; vector y celula huesped; metodo para producir asparraginasa; composicion que comprende la variante; uso de la variante de asparraginasa; proceso
CL200801128A CL2008001128A1 (es) 2007-04-20 2008-04-18 Asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos, vector y celula huesped; metodo para producir asparraginasa; composicion que comprende variante; uso de la variante de asparraginasa; proceso de elaboracion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL200801129A CL2008001129A1 (es) 2007-04-20 2008-04-18 Variente de asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos; vector y celula huesped; metodo para producir asparraginasa; composicion que comprende la variante; uso de la variante de asparraginasa; proceso

Country Status (14)

Country Link
US (3) US20100136169A1 (es)
EP (1) EP2137306B1 (es)
JP (1) JP2010524448A (es)
AR (1) AR066410A1 (es)
AU (1) AU2008240797A1 (es)
BR (1) BRPI0810481B1 (es)
CA (1) CA2682677A1 (es)
CL (2) CL2008001129A1 (es)
DK (1) DK2137306T3 (es)
EA (1) EA017305B1 (es)
ES (1) ES2550362T3 (es)
IL (1) IL201018A0 (es)
MX (1) MX2009011256A (es)
WO (1) WO2008128975A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6730832B1 (en) 2001-09-10 2004-05-04 Luis Mayan Dominguez High threonine producing lines of Nicotiana tobacum and methods for producing
EP2851424B1 (en) 2007-03-09 2016-09-21 Novozymes A/S Thermostable asparaginases
CA2683078C (en) 2007-04-20 2016-03-29 Dsm Ip Assets B.V. Asparaginase enzyme variants and uses thereof
US20110129569A1 (en) 2009-11-26 2011-06-02 Dsm Ip Assets B.V. Method to produce fried vegetable products
CN102869772A (zh) * 2010-04-27 2013-01-09 帝斯曼知识产权资产管理有限公司 新颖的天冬酰胺酶
WO2012007192A1 (en) * 2010-07-14 2012-01-19 Nestec S.A. Asparaginase from basidiomycetes
CA2817224A1 (en) 2010-11-19 2012-05-24 Novozymes North America, Inc. Processes of producing a fermentation product
WO2012158320A1 (en) 2011-05-13 2012-11-22 Baker Hughes Incorporated Method of using asparaginase as a polyacrylamide enzyme breaker
US8716571B2 (en) 2011-09-21 2014-05-06 Reynolds Technologies, Inc. Tobacco having reduced amounts of amino acids and methods for producing such lines
BR112014006735B1 (pt) * 2011-09-21 2021-06-22 Reynolds Technologies, Inc Método de produção de uma planta de tabaco modificada e produto de tabaco
US9137958B2 (en) 2012-02-08 2015-09-22 Reynolds Technologies, Inc. Tobacco having altered amounts of environmental contaminants
CA2881952C (en) * 2012-08-17 2021-02-16 Novozymes A/S Method for producing a food product
BR112015003257A2 (pt) 2012-08-17 2017-11-14 Novozymes As variante de asparaginase, métodos para produção de um produto alimentar a partir de um material alimentar, para produção de uma variante de asparaginase e para obtenção de uma variante de asparaginase, polinucleotídeo isolado, constructo de ácido nucleico, vetor de expressão, e, célula hospedeira
KR20220002721A (ko) 2013-11-21 2022-01-06 엔테그리스, 아이엔씨. 플라즈마 시스템에서 사용되는 챔버 구성요소를 위한 표면 코팅
EP3197291A1 (en) 2014-07-04 2017-08-02 West Systems S.r.l Method and composition to reduce the formation of acrylamide in fresh or pre-fried foods to be subjected to heat treatment
RU2764014C2 (ru) * 2015-07-07 2022-01-12 Ренессанс Байосайенс Корп. Создание уменьшающих уровень аспарагина дрожжей путем адаптивной эволюции и их применение для уменьшения образования акриламида
AU2018354067B2 (en) 2017-10-27 2023-03-30 Pfenex Inc. Method for production of recombinant Erwinia asparaginase
US20210299233A1 (en) 2018-07-12 2021-09-30 The Children's Medical Center Corporation Method for treating cancer
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
WO2022211829A1 (en) 2021-03-30 2022-10-06 Jazz Pharmaceuticals Ireland Ltd. Dosing of recombinant l-asparaginase

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3819540B2 (ja) * 1996-06-07 2006-09-13 株式会社林原生物化学研究所 Ｌ−アスパラギナーゼ活性を有する哺乳類由来のポリペプチド
US7037540B2 (en) 2002-09-19 2006-05-02 Frito-Lay North America, Inc. Method for reducing acrylamide formation in thermally processed foods
US7524519B2 (en) 2002-09-20 2009-04-28 The Procter & Gamble Company Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce
DK1553848T3 (da) 2002-10-11 2008-01-21 Novozymes As Fremgangsmåde til fremstilling af et varmebehandlet produkt
US20040101607A1 (en) 2002-11-22 2004-05-27 The Procter & Gamble Company Method for reducing acrylamide in foods, foods having reduced levels of acrylamide, and article of commerce
CN100569101C (zh) * 2002-12-19 2009-12-16 帝斯曼知识产权资产管理有限公司 新颖的食物制造方法

Also Published As

Publication number Publication date
EP2137306A1 (en) 2009-12-30
ES2550362T3 (es) 2015-11-06
US20120045549A1 (en) 2012-02-23
CA2682677A1 (en) 2008-10-30
MX2009011256A (es) 2009-11-05
CL2008001129A1 (es) 2008-06-13
BRPI0810481B1 (pt) 2022-05-17
US20100136169A1 (en) 2010-06-03
EA200901432A1 (ru) 2010-04-30
AR066410A1 (es) 2009-08-19
BRPI0810481A2 (pt) 2014-10-07
JP2010524448A (ja) 2010-07-22
IL201018A0 (en) 2011-08-01
EA017305B1 (ru) 2012-11-30
US8323948B2 (en) 2012-12-04
DK2137306T3 (en) 2015-10-26
US20130023029A1 (en) 2013-01-24
AU2008240797A1 (en) 2008-10-30
WO2008128975A1 (en) 2008-10-30
EP2137306B1 (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CL2008001128A1 (es) Asparraginasa; secuencia de acido nucleico que la codifica; construccion de acidos nucleicos, vector y celula huesped; metodo para producir asparraginasa; composicion que comprende variante; uso de la variante de asparraginasa; proceso de elaboracion
CL2007002987A1 (es) Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para tratar enfermedades relacionadas con notch3.
CL2007002989A1 (es) Anticuerpos anti-notch3; acido nucleico que los codifica; vector y celula que lo comprende; metodo de produccion; y su uso para el diagnostico de enfermedades relacionadas con notch3.
CL2007002835A1 (es) Anticuerpo monoclonal especifico para el receptor cxcr4; acido nucleico que lo codifica; vector y celula que lo comprenden; metodo de produccion; inmunoconjugado y composicion que lo comprende; y su uso para tratar cancer, trastornos inflamatorios y
CL2013002438A1 (es) Metodo para crear modificación genética en una célula de ganado usando acido nucleico que codifica una molecula efectora y nucleasas efectoras (talens)
CL2008000839A1 (es) Anticuerpo anti-ige/m1'; acido nucleico que lo codifica; vector y celula huesped; proceso de produccion; composicion que comprende al anticuerpo; y su uso para tratar trastornos mediados por ige.
SMT201500210B (it) Composizioni applicazioni di gel rimovibili per unghie e metodi per il loro uso
CL2013000074A1 (es) Proteina de union con capacidad de unir un par de antigenos; acido nucleico que la codifica; vector; celula huesped; metodo de produccion; composicion farmaceutica que la comprende; conjugado que comprende dicha proteina de union; y sus usos.
ES2531167T5 (es) Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
CL2007003623A1 (es) Proteina de enlace multivalente monocatenaria con funcion efectora; acido nucleico que la codifica; vector y celula huesped; metodo de produccion; composicion farmaceutica que la comprende; y metodo para tratar trastornos proliferativos.
BRPI0916964A2 (pt) polipetídeo, anticorpo, ácido nucléico, vetor, célula hospedeira, método para produzir um polipeptídeo, composição e uso do polipeptídeo
BRPI0814781A2 (pt) Proteína, sequência de ácido nucleico, método para a produção de ácido itacônico, vetor, célula hospedeira, e, uso de um ácido cis-aconítico
CL2008000460A1 (es) Proteina de fusion que comprende un polipeptido inmunoglobulina; acido nucleico que la codifica; vector y celula huesped; metodo de produccion; composicion que la comprende; y su uso para tratar un trastorno en un sujeto.
CL2007003445A1 (es) Compuesto aislado de union a interleuquina-6 (il-6) humana; acido nucleico que lo codifica; metodo de produccion; composicion que los comprende; y su uso para tratar desordenes asociados con il-6.
EP2300938A4 (en) METHOD FOR THE REPRESENTATION OF OBJECTS AND RELATIONSHIPS IN DATABASES, DIRECT AND APPLICATIONS AS SETS
CL2013000338A1 (es) Proteina de union que tiene la capacidad de unirse a interleuquina 1beta y a la interleuquina 17; conjugado de proteina de union cristalizada; acido nucleico, vector, célula huesped; metodo para producir una proteina de unión; composicion farmacéutica que comprende la proteina de unión.
BRPI0817811A2 (pt) Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas.
BRPI0922355A2 (pt) ácidos nucléicos, métodos para reduzir a expressão de um gene em uma célula in vitro, uso de um ácido nucléico, complexo de rna e uso do complexo de rna
BRPI0921995A2 (pt) processo de deslocamento de gás para água , e, uso de um adsorvente.
CL2013001403A1 (es) Anticuerpo monoclonal anti-ccl20 o un fragmento de unión del mismo; molecula de acido nucleico que lo codifica; vector; celula huesped; metodo de produccion; composicion que lo comprende; y su uso.
BRPI0913739A2 (pt) Composição líquida, método, e, uso de composição
CL2007002225A1 (es) Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
BRPI0810874A2 (pt) Líquido iônico, proceso para preparar um líquido iônico, e, uso de líquidos iônicos.
CL2008001887A1 (es) Proteinas de union a antigeno que se unen al receptor activado por proteasas 2 (par-2); acido nucleico que las codifica; vector y celula huesped; metodo de produccion; y composicion que las comprende.
BRPI0919388A2 (pt) ácido succínico e método para produzir o mesmo.